Beyond Celiac's Impact

Read More Beyond Celiac Impacts »

Participation in the U.S. Food and Drug Administration (FDA) Patient Representative Program

In 2012, Alice Bast, Beyond Celiac President and CEO and Kristin Voorhees, MA, Beyond Celiac Director of Healthcare Initiatives were chosen to serve as FDA Patient Representatives for celiac disease as part of FDA’s program to ensure that patients have a voice in its regulatory decision-making. This program trains Representatives about policies, procedures and regulations through formal education such as webinars and an annual two-day workshop for first-year representatives.

OUR PARTNERS